Biolojic Design

Biolojic Design

Pre-clinical
Cambridge, United StatesFounded 2009biolojic.com

We’re redefining what antibodies can do. CAPABILITIES Pioneering two new capabilities for natural human antibodies We leverage our platform to engineer epitope specific antibodies, such as agonists, antagonists, conformation-specific or conditional binders; or multibodies, which are multi-specific symmetrical IgG binding to more than one target on the same Fab. Biolojic’s multibodies will solve key challenges in

Founded
2009
Focus
AI / Machine LearningAntibodiesBiologics

About

We’re redefining what antibodies can do. CAPABILITIES Pioneering two new capabilities for natural human antibodies We leverage our platform to engineer epitope specific antibodies, such as agonists, antagonists, conformation-specific or conditional binders; or multibodies, which are multi-specific symmetrical IgG binding to more than one target on the same Fab. Biolojic’s multibodies will solve key challenges in

Funding History

4

Total raised: $140M

Series B$50MaMoon FundJun 15, 2022
Series B$50MIAG Capital PartnersJun 15, 2022
Series A$20MIsrael Biotech FundOct 15, 2020
Series A$20MIAG Capital PartnersOct 15, 2020

Company Info

TypePrivate
Founded2009
LocationCambridge, United States
StagePre-clinical
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile